Skip to main content
. 2020 Jan 23;35(3):612–619. doi: 10.1111/jocs.14427

Table 4.

Details of in‐hospital deaths

Age, y Sex Euroscore II MRT to surgery, y NYHA Surgical procedure ECC time, min Cross‐clamp time, min Interval surgery‐death, d Indication for rethoracotomy Cause of death Autopsy findings
82 F 3.60 23 3 AVR N/A N/A 4 Hemothorax Refractory shock Diffuse myocardial damage and early hepatic necrosis
82 F 2.97 2 CABG + AVR 237 135 2 MOF after DC postinfarction after graft failure
66 F 6.59 33 3 CABG,AVR,MVR 286 169 38 Hemorrhage MOF after LVF and RVF
69 F 6.64 20 2 AVR 87 45 9 MOF after Sepsis + forward and backward failure
67 F 9.49 2 3 ASD closure, PAPVC rerouting, TVP, MVP 174 92 41 Post‐CPR + signs of Mediastinitis MOF with signs of systemic infection Recent left ventricular infarction, lung edema, chronic DC, paravalvular dehiscention
64 F 5.31 10 2 ASD/VSD closure, MVR, TVP 205 94 8 First LVAD placement MOF after cardiac and distributive shock Generalized edema, signs of (sub)acute DC, toxic myocardial damage
Second Hematoma

Abbreviations: ASD, atrial septum defect; AVR, aortic valve replacement; CABG, coronary artery bypass graft surgery; CPR, cardiopulmonary resuscitation; DC, cardiac decompensation; ECC, extracorporal circulation time; F, female; LVAD, left ventricular assist device; LVF, left ventricle failure; min, minutes; MOF, multiorgan failure; MRT, mediastinal radiotherapy; MVP, mitral valve plasty; MVR, mitral valve replacement; N/A, not applicable; NYHA, New York Heart Association; PAPVC, partial anomalous pulmonary venous connection; RVF, right ventricle failure; TVP, tricuspid valve plasty; VSD, ventricular septum defect.